Industry: Chemical & Material
Published Date: 2024-11-26
Pages: 125 Pages
Report ld: 3385677
Request Sample
Customized Report
Proparacaine API Market Size(US$)

CAGR 2024-2030
4.3%
Market Size,2030
USD 321
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Proparacaine API revenue was US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).
In United States the Proparacaine API revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Proparacaine API market, also covers the segmentation data of other regions in regional level and county level.
Proparacaine is a local anesthetic used primarily in ophthalmology. Proparacaine temporarily paralyzes the surface of the eye by blocking nerve signal transmission, making it useful for diagnostic and minor surgical procedures such as intraocular pressure measurement or foreign body removal.
The global key players of Proparacaine API include Xi'an Tian Guangyuan Biotech, Siegfried, Xianqiang Pharmaceutical, Lifeon, MITACHIEVE, WUHAN XINXINJIALI BIOTECHNOLOGY, Angle Bio Pharma, Fengchen Group, Conscientia Industrial, Pharmaffiliates, etc. The global five biggest players hold a share of % in 2023.
Proparacaine API market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Proparacaine API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Proparacaine API market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Proparacaine API definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Proparacaine API companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Proparacaine API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Proparacaine API sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Proparacaine API Product Introduction
1.2 Global Proparacaine API Outlook 2019 VS 2023 VS 2030
1.2.1 Global Proparacaine API Sales in US$ Million for the Year 2019-2030
1.2.2 Global Proparacaine API Sales in Volume for the Year 2019-2030
1.3 United States Proparacaine API Outlook 2019 VS 2023 VS 2030
1.3.1 United States Proparacaine API Sales in US$ Million for the Year 2019-2030
1.3.2 United States Proparacaine API Sales in Volume for the Year 2019-2030
1.4 Proparacaine API Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Proparacaine API in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Proparacaine API Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Proparacaine API Market Dynamics
1.5.1 Proparacaine API Industry Trends
1.5.2 Proparacaine API Market Drivers
1.5.3 Proparacaine API Market Challenges
1.5.4 Proparacaine API Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Proparacaine API by Type
2.1 Proparacaine API Market by Type
2.1.1 Purity Above 99%
2.1.2 Purity Below 99%
2.2 Global Proparacaine API Market Size by Type
2.2.1 Global Proparacaine API Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Proparacaine API Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Proparacaine API Market Size by Type
2.3.1 United States Proparacaine API Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Proparacaine API Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Proparacaine API by Application
3.1 Proparacaine API Market by Application
3.1.1 Ophthalmic Procedures
3.1.2 Diagnostic Use
3.2 Global Proparacaine API Market Size by Application
3.2.1 Global Proparacaine API Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Proparacaine API Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Proparacaine API Market Size by Application
3.3.1 United States Proparacaine API Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Proparacaine API Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Proparacaine API Competitor Landscape by Company
4.1 Global Proparacaine API Market Size by Company
4.1.1 Global Key Manufacturers of Proparacaine API, Ranked by Revenue (2023)
4.1.2 Global Proparacaine API Revenue by Manufacturer (2019-2024)
4.1.3 Global Proparacaine API Sales by Manufacturer (2019-2024)
4.1.4 Global Proparacaine API Price by Manufacturer (2019-2024)
4.2 Global Proparacaine API Concentration Ratio (CR)
4.2.1 Proparacaine API Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Proparacaine API in 2023
4.2.3 Global Proparacaine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Proparacaine API, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Proparacaine API, Product Offered and Application
4.5 Global Key Manufacturers of Proparacaine API, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Proparacaine API Market Size by Company
4.7.1 Key Players of Proparacaine API in United States, Ranked by Revenue (2023)
4.7.2 United States Proparacaine API Revenue by Players (2019-2024)
4.7.3 United States Proparacaine API Sales by Players (2019-2024)
5 Global Proparacaine API Market Size by Region
5.1 Global Proparacaine API Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Proparacaine API Market Size in Volume by Region (2019-2030)
5.2.1 Global Proparacaine API Sales in Volume by Region: 2019-2024
5.2.2 Global Proparacaine API Sales in Volume Forecast by Region (2025-2030)
5.3 Global Proparacaine API Market Size in Value by Region (2019-2030)
5.3.1 Global Proparacaine API Sales in Value by Region: 2019-2024
5.3.2 Global Proparacaine API Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Proparacaine API Market Size YoY Growth 2019-2030
6.2 Americas Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Proparacaine API Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Proparacaine API Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Proparacaine API Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Proparacaine API Market Size YoY Growth 2019-2030
7.2 EMEA Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Proparacaine API Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Proparacaine API Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Proparacaine API Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Proparacaine API Market Size YoY Growth 2019-2030
8.2 China Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Proparacaine API Market Size YoY Growth 2019-2030
9.2 APAC Proparacaine API Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Proparacaine API Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Proparacaine API Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Proparacaine API Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Proparacaine API Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Xi'an Tian Guangyuan Biotech
10.1.1 Xi'an Tian Guangyuan Biotech Company Information
10.1.2 Xi'an Tian Guangyuan Biotech Description and Business Overview
10.1.3 Xi'an Tian Guangyuan Biotech Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Xi'an Tian Guangyuan Biotech Proparacaine API Products Offered
10.1.5 Xi'an Tian Guangyuan Biotech Recent Development
10.2 Siegfried
10.2.1 Siegfried Company Information
10.2.2 Siegfried Description and Business Overview
10.2.3 Siegfried Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Siegfried Proparacaine API Products Offered
10.2.5 Siegfried Recent Development
10.3 Xianqiang Pharmaceutical
10.3.1 Xianqiang Pharmaceutical Company Information
10.3.2 Xianqiang Pharmaceutical Description and Business Overview
10.3.3 Xianqiang Pharmaceutical Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Xianqiang Pharmaceutical Proparacaine API Products Offered
10.3.5 Xianqiang Pharmaceutical Recent Development
10.4 Lifeon
10.4.1 Lifeon Company Information
10.4.2 Lifeon Description and Business Overview
10.4.3 Lifeon Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Lifeon Proparacaine API Products Offered
10.4.5 Lifeon Recent Development
10.5 MITACHIEVE
10.5.1 MITACHIEVE Company Information
10.5.2 MITACHIEVE Description and Business Overview
10.5.3 MITACHIEVE Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.5.4 MITACHIEVE Proparacaine API Products Offered
10.5.5 MITACHIEVE Recent Development
10.6 WUHAN XINXINJIALI BIOTECHNOLOGY
10.6.1 WUHAN XINXINJIALI BIOTECHNOLOGY Company Information
10.6.2 WUHAN XINXINJIALI BIOTECHNOLOGY Description and Business Overview
10.6.3 WUHAN XINXINJIALI BIOTECHNOLOGY Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.6.4 WUHAN XINXINJIALI BIOTECHNOLOGY Proparacaine API Products Offered
10.6.5 WUHAN XINXINJIALI BIOTECHNOLOGY Recent Development
10.7 Angle Bio Pharma
10.7.1 Angle Bio Pharma Company Information
10.7.2 Angle Bio Pharma Description and Business Overview
10.7.3 Angle Bio Pharma Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Angle Bio Pharma Proparacaine API Products Offered
10.7.5 Angle Bio Pharma Recent Development
10.8 Fengchen Group
10.8.1 Fengchen Group Company Information
10.8.2 Fengchen Group Description and Business Overview
10.8.3 Fengchen Group Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Fengchen Group Proparacaine API Products Offered
10.8.5 Fengchen Group Recent Development
10.9 Conscientia Industrial
10.9.1 Conscientia Industrial Company Information
10.9.2 Conscientia Industrial Description and Business Overview
10.9.3 Conscientia Industrial Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Conscientia Industrial Proparacaine API Products Offered
10.9.5 Conscientia Industrial Recent Development
10.10 Pharmaffiliates
10.10.1 Pharmaffiliates Company Information
10.10.2 Pharmaffiliates Description and Business Overview
10.10.3 Pharmaffiliates Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Pharmaffiliates Proparacaine API Products Offered
10.10.5 Pharmaffiliates Recent Development
10.11 Enomark
10.11.1 Enomark Company Information
10.11.2 Enomark Description and Business Overview
10.11.3 Enomark Proparacaine API Sales, Revenue and Gross Margin (2019-2024)
10.11.4 Enomark Proparacaine API Products Offered
10.11.5 Enomark Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Proparacaine API Industry Chain Analysis
11.2 Proparacaine API Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Proparacaine API Production Mode & Process
11.4 Proparacaine API Sales and Marketing
11.4.1 Proparacaine API Sales Channels
11.4.2 Proparacaine API Distributors
11.5 Proparacaine API Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Proparacaine API market is projected to grow from US$ 259 million in 2025 to US$ 346 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 163
USD 4900.00
(Single User License)
The global Proparacaine API market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 346 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 96
USD 4250.00
(Single User License)
The global Proparacaine API market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 346 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 142
USD 2900.00
(Single User License)
The global market for Proparacaine API was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 346 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 120
USD 3950.00
(Single User License)
The global Proparacaine API market is projected to grow from US$ 249 million in 2024 to US$ 333 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 161
USD 4900.00
(Single User License)
The global Proparacaine API market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 99
USD 4250.00
(Single User License)
The global market for Proparacaine API was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 116
USD 3950.00
(Single User License)
The global market for Proparacaine API was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Valued at US$ 249 million in 2024, the global Proparacaine API market is forecast to reach US$ 321 million by 2030, at a CAGR of 4.3% during the forecast period.
Published Date: 2024-11-26
Pages: 164
USD 4900.00
(Single User License)
The global market for Proparacaine API was estimated to be worth US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published Date: 2024-11-26
Pages: 129
USD 3950.00
(Single User License)
The global Proparacaine API market is projected to grow from US$ 259 million in 2025 to US$ 346 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 163
The global Proparacaine API market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 346 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 96
The global Proparacaine API market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 346 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 142
The global market for Proparacaine API was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 346 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 120
The global Proparacaine API market is projected to grow from US$ 249 million in 2024 to US$ 333 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 161
The global Proparacaine API market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
The global market for Proparacaine API was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 116
The global market for Proparacaine API was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 96
Valued at US$ 249 million in 2024, the global Proparacaine API market is forecast to reach US$ 321 million by 2030, at a CAGR of 4.3% during the forecast period.
Published: 2024-11-26
Pages: 164
The global market for Proparacaine API was estimated to be worth US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published: 2024-11-26
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now